Suppr超能文献

用于病毒性疾病的细胞疗法:一个新的前沿领域。

Cell therapies for viral diseases: a new frontier.

作者信息

Nardo David, Maddox Emileigh G, Riley James L

机构信息

Department of Microbiology and Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, 19104, USA.

出版信息

Semin Immunopathol. 2025 Jan 2;47(1):5. doi: 10.1007/s00281-024-01031-8.

Abstract

Despite advances in medicine and antimicrobial research, viral infections continue to pose a major threat to human health. While major strides have been made in generating vaccines and small molecules to combat emerging pathogens, new modalities of treatment are warranted in diseases where there is a lack of treatment options, or where treatment cannot fully eradicate pathogens, as in HIV infection. Cellular therapies, some of which are FDA approved for treating cancer, take advantage of our developing understanding of the immune system, and harness this knowledge to enhance, or direct, immune responses toward infectious agents. As with cancer, viruses that evade immunity, do so by avoiding immune recognition or by redirecting the cellular responses that would eradicate them. As such, infusing virus specific immune cells has the potential to improve patient outcomes and should be investigated as a potential tool in the arsenal to fight infection. The present manuscript summarizes key findings made using cellular therapies for the treatment of viral infections, focusing on the potential that these strategies might have in controlling disease.

摘要

尽管医学和抗菌研究取得了进展,但病毒感染仍然对人类健康构成重大威胁。虽然在研发疫苗和小分子以对抗新出现的病原体方面已经取得了重大进展,但在缺乏治疗选择或治疗无法完全根除病原体的疾病(如艾滋病毒感染)中,仍需要新的治疗方式。细胞疗法,其中一些已获得美国食品药品监督管理局(FDA)批准用于治疗癌症,它利用了我们对免疫系统不断深入的了解,并利用这些知识来增强或引导针对感染因子的免疫反应。与癌症一样,逃避免疫的病毒是通过避免免疫识别或重定向会根除它们的细胞反应来实现的。因此,输注病毒特异性免疫细胞有可能改善患者的治疗效果,应该作为对抗感染的潜在工具进行研究。本手稿总结了使用细胞疗法治疗病毒感染的关键发现,重点关注这些策略在控制疾病方面可能具有的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c68/11695571/848c87f3ece5/281_2024_1031_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验